Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

NECTIN4 (PVRL4) as Putative Therapeutic Target for a Specific Subtype of High Grade Serous Ovarian Cancer-An Integrative Multi-Omics Approach.

Bekos C, Muqaku B, Dekan S, Horvat R, Polterauer S, Gerner C, Aust S, Pils D.

Cancers (Basel). 2019 May 20;11(5). pii: E698. doi: 10.3390/cancers11050698.

2.

Curcumin exerts its antitumor effects in a context dependent fashion.

Kreutz D, Sinthuvanich C, Bileck A, Janker L, Muqaku B, Slany A, Gerner C.

J Proteomics. 2018 Jun 30;182:65-72. doi: 10.1016/j.jprot.2018.05.007. Epub 2018 May 9.

PMID:
29751106
3.

Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastases.

Zila N, Bileck A, Muqaku B, Janker L, Eichhoff OM, Cheng PF, Dummer R, Levesque MP, Gerner C, Paulitschke V.

Clin Proteomics. 2018 Mar 9;15:13. doi: 10.1186/s12014-018-9189-x. eCollection 2018.

4.

Combined Proteome and Eicosanoid Profiling Approach for Revealing Implications of Human Fibroblasts in Chronic Inflammation.

Tahir A, Bileck A, Muqaku B, Niederstaetter L, Kreutz D, Mayer RL, Wolrab D, Meier SM, Slany A, Gerner C.

Anal Chem. 2017 Feb 7;89(3):1945-1954. doi: 10.1021/acs.analchem.6b04433. Epub 2017 Jan 20.

PMID:
28208246
5.

Multi-omics Analysis of Serum Samples Demonstrates Reprogramming of Organ Functions Via Systemic Calcium Mobilization and Platelet Activation in Metastatic Melanoma.

Muqaku B, Eisinger M, Meier SM, Tahir A, Pukrop T, Haferkamp S, Slany A, Reichle A, Gerner C.

Mol Cell Proteomics. 2017 Jan;16(1):86-99. doi: 10.1074/mcp.M116.063313. Epub 2016 Nov 22.

6.

Coffee consumption modulates inflammatory processes in an individual fashion.

Muqaku B, Tahir A, Klepeisz P, Bileck A, Kreutz D, Mayer RL, Meier SM, Gerner M, Schmetterer K, Gerner C.

Mol Nutr Food Res. 2016 Dec;60(12):2529-2541. doi: 10.1002/mnfr.201600328. Epub 2016 Aug 30.

PMID:
27425673
7.

Contribution of Human Fibroblasts and Endothelial Cells to the Hallmarks of Inflammation as Determined by Proteome Profiling.

Slany A, Bileck A, Kreutz D, Mayer RL, Muqaku B, Gerner C.

Mol Cell Proteomics. 2016 Jun;15(6):1982-97. doi: 10.1074/mcp.M116.058099. Epub 2016 Mar 29.

8.

Proteomic and Metabolomic Analyses Reveal Contrasting Anti-Inflammatory Effects of an Extract of Mucor Racemosus Secondary Metabolites Compared to Dexamethasone.

Meier SM, Muqaku B, Ullmann R, Bileck A, Kreutz D, Mader JC, Knasmüller S, Gerner C.

PLoS One. 2015 Oct 23;10(10):e0140367. doi: 10.1371/journal.pone.0140367. eCollection 2015.

9.

Targeting breast cancer-associated fibroblasts to improve anti-cancer therapy.

Slany A, Bileck A, Muqaku B, Gerner C.

Breast. 2015 Oct;24(5):532-8. doi: 10.1016/j.breast.2015.06.009. Epub 2015 Jul 22.

PMID:
26210685
10.

Impact of a synthetic cannabinoid (CP-47,497-C8) on protein expression in human cells: evidence for induction of inflammation and DNA damage.

Bileck A, Ferk F, Al-Serori H, Koller VJ, Muqaku B, Haslberger A, Auwärter V, Gerner C, Knasmüller S.

Arch Toxicol. 2016 Jun;90(6):1369-82. doi: 10.1007/s00204-015-1569-7. Epub 2015 Jul 21.

PMID:
26194647
11.

Quantification of cytokines secreted by primary human cells using multiple reaction monitoring: evaluation of analytical parameters.

Muqaku B, Slany A, Bileck A, Kreutz D, Gerner C.

Anal Bioanal Chem. 2015 Aug;407(21):6525-36. doi: 10.1007/s00216-015-8817-9. Epub 2015 Jun 20.

PMID:
26092402
12.

Comprehensive assessment of proteins regulated by dexamethasone reveals novel effects in primary human peripheral blood mononuclear cells.

Bileck A, Kreutz D, Muqaku B, Slany A, Gerner C.

J Proteome Res. 2014 Dec 5;13(12):5989-6000. doi: 10.1021/pr5008625. Epub 2014 Nov 5.

PMID:
25347463

Supplemental Content

Loading ...
Support Center